<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37598150</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Health disparities in COVID-19: immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California.</ArticleTitle><Pagination><StartPage>1584</StartPage><MedlinePgn>1584</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-16462-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Health disparities in underserved communities, such as inadequate healthcare access, impact COVID-19 disease outcomes. These disparities are evident in Hispanic populations nationwide, with disproportionately high infection and mortality rates. Furthermore, infected individuals can develop long COVID with sustained impacts on quality of life. The goal of this study was to identify immune and endothelial factors that are associated with COVID-19 outcomes in Riverside County, a high-risk and predominantly Hispanic community, and investigate the long-term impacts of COVID-19 infection.</AbstractText><AbstractText Label="METHODS">112 participants in Riverside County, California, were recruited according to the following criteria: healthy control (n&#x2009;=&#x2009;23), outpatients with moderate infection (outpatient, n&#x2009;=&#x2009;33), ICU patients with severe infection (hospitalized, n&#x2009;=&#x2009;33), and individuals recovered from moderate infection (n&#x2009;=&#x2009;23). Differences in outcomes between Hispanic and non-Hispanic individuals and presence/absence of co-morbidities were evaluated. Circulating immune and vascular biomarkers were measured by ELISA, multiplex analyte assays, and flow cytometry. Follow-up assessments for long COVID, lung health, and immune and vascular changes were conducted after recovery (n&#x2009;=&#x2009;23) including paired analyses of the same participants.</AbstractText><AbstractText Label="RESULTS">Compared to uninfected controls, the severe infection group had a higher proportion of Hispanic individuals (n&#x2009;=&#x2009;23, p&#x2009;=&#x2009;0.012) than moderate infection (n&#x2009;=&#x2009;8, p&#x2009;=&#x2009;0.550). Disease severity was associated with changes in innate monocytes and neutrophils, lymphopenia, disrupted cytokine production (increased IL-8 and IP-10/CXCL10 but reduced IFN&#x3bb;2/3 and IFN&#x3b3;), and increased endothelial injury (myoglobin, VCAM-1). In the severe infection group, a machine learning model identified LCN2/NGAL, IL-6, and monocyte activation as parameters associated with fatality while anti-coagulant therapy was associated with survival. Recovery from moderate COVID infection resulted in long-term immune changes including increased monocytes/lymphocytes and decreased neutrophils and endothelial markers. This group had a lower proportion of co-morbidities (n&#x2009;=&#x2009;8, p&#x2009;=&#x2009;1.0) but still reported symptoms associated with long COVID despite recovered pulmonary function.</AbstractText><AbstractText Label="CONCLUSION">This study indicates increased severity of COVID-19 infection in Hispanic individuals of Riverside County, California. Infection resulted in immunological and vascular changes and long COVID symptoms that were sustained for up to 11&#xa0;months, however, lung volume and airflow resistance was recovered. Given the immune and behavioral impacts of long COVID, the potential for increased susceptibility to infections and decreased quality of life in high-risk populations warrants further investigation.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bergersen</LastName><ForeName>Kristina V</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pham</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Jiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ulrich</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Riverside University Health System Medical Center, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merrill</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Riverside Medical Center, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaama</LastName><ForeName>Sumaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xinru</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harahap-Carrillo</LastName><ForeName>Indira S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichii</LastName><ForeName>Keita</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frost</LastName><ForeName>Shyleen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaul</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godzik</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinrich</LastName><ForeName>Erica C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.. erica.heinrich@medsch.ucr.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Meera G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, U.S.. meera.nair@medsch.ucr.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DA052209</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD026929</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 MD013368</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Health disparities</Keyword><Keyword MajorTopicYN="N">Hispanic</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Severe infection</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>20</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>19</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37598150</ArticleId><ArticleId IdType="pmc">PMC10439554</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-16462-5</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-16462-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed 13 Feb 2023.</Citation></Reference><Reference><Citation>COVID data tracker. https://covid.cdc.gov/covid-data-tracker/#demographics. Accessed 13 Feb 2023.</Citation></Reference><Reference><Citation>Khatana SAM, Groeneveld PW. Health disparities and the Coronavirus Disease 2019 (COVID-19) pandemic in the USA. J Gen Intern Med. 2020;35:2431&#x2013;2432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251802</ArticleId><ArticleId IdType="pubmed">32462564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Hamadi HY, Haley DR, Xu J, Tafili A, Spaulding AC. COVID-19 deaths and the impact of health disparities, hospital characteristics, community, social distancing, and health system competition. Popul Health Manag. 2022;25(6):807&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">36576382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto NM, Freund D, Ogata P, Diaz L, Ibarrola A, Desai M, Aspelund T, Gluckstein D. Correlates of coronavirus disease 2019 inpatient mortality at a southern california community hospital with a predominantly Hispanic/Latino adult population. Open Forum Infect Dis. 2023;10(1):ofad011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887269</ArticleId><ArticleId IdType="pubmed">36726553</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao A, Alnababteh MH, Avila-Quintero VJ, Flores JM, Laing NE, Boyd DA, et al. Association between patient race and ethnicity and outcomes with COVID-19: a retrospective analysis from a large mid-atlantic health system. J Intensive Care Med. 2023;38(5):472&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813659</ArticleId><ArticleId IdType="pubmed">36594202</ArticleId></ArticleIdList></Reference><Reference><Citation>Riverside County COVID-19 data and reports. https://coronavirus-countyofriverside.hub.arcgis.com/. Accessed 13 Feb 2023.</Citation></Reference><Reference><Citation>Hazeldine J, Lord JM. Neutrophils and COVID-19: active participants and rational therapeutic targets.&#xa0;Front Immunol. 2021;12. 10.3389/fimmu.2021.680134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206563</ArticleId><ArticleId IdType="pubmed">34149717</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera VLM, Bosch NA, Lok JJ, Nguyen MQ, Lenae KA, deKay JT, et al. Circulating neutrophil extracellular trap (NET)-forming 'rogue' neutrophil subset, immunotype [DEspR+CD11b+], mediate multi-organ failure in COVID-19 - an observational study. Res Sq. 2023 doi: 10.21203/rs.3.rs-2479844/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-2479844/v1</ArticleId><ArticleId IdType="pmc">PMC10111078</ArticleId><ArticleId IdType="pubmed">37096233</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R. From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem inflammatory syndrome in children. Int J Mol Sci. 2023;24(3):3001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917907</ArticleId><ArticleId IdType="pubmed">36769320</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice CM, Lewis P, Ponce-Garcia FM, Gibbs W, Groves S, Cela D, et al. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19. Life Sci Alliance. 2023;6(2). 10.26508/lsa.202201658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9748722</ArticleId><ArticleId IdType="pubmed">36622345</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal VNC, Andrade MMS, Teixeira FME, Cambui RAG, Roa M, Marra LG, et al. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils. Scand J Immunol. 2022;97(3). 10.1111/sji.13247.</Citation><ArticleIdList><ArticleId IdType="pubmed">36541819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstedt S, Piersiala K, Petro M, Karlsson A, K&#xe5;gedal &#xc5;, Kumlien Geor&#xe9;n S, Cardell LO. A prolonged innate systemic immune response in COVID-19. Sci Rep. 2022;12(1):9915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9200737</ArticleId><ArticleId IdType="pubmed">35705573</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci. 2021;269:119010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834345</ArticleId><ArticleId IdType="pubmed">33454368</ArticleId></ArticleIdList></Reference><Reference><Citation>Satta S, Meng Z, Hernandez R, Cavallero S, Zhou T, Hsiai TK, Zhou C. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages. Theranostics. 2022;12(6):2639&#x2013;2657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8965482</ArticleId><ArticleId IdType="pubmed">35401811</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, Thursz M, Manousou P, Corbett R, Goldin R, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245&#x2013;e253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas AG, Chaliasou AL, Panagopoulos A, Dede K, Daskalopoulou S, Moniem E, et al. Kinetics of immune subsets in COVID-19 patients treated with corticosteroids. Viruses. 2022;15(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9865280</ArticleId><ArticleId IdType="pubmed">36680091</ArticleId></ArticleIdList></Reference><Reference><Citation>Westmeier J, Paniskaki K, Karak&#xf6;se Z, Werner T, Sutter K, Dolff S, et al. Impaired cytotoxic CD8(+) T cell response in elderly COVID-19 patients. mBio. 2020;11(5). 10.1128/mBio.02243-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502863</ArticleId><ArticleId IdType="pubmed">32948688</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Jiang Z, Meulendijks ER, Baylan U, Waas ISE, Bugiani M, Tuinman PR, Fronczek J, Heunks LMA, de Groot JR, et al. Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients. Cardiovasc Pathol. 2023;64:107524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839463</ArticleId><ArticleId IdType="pubmed">36649811</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, Wang Z, Wei X, Tang J, Li Y, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65):1741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Getachew B, Landis HE, Manaye KF, Tizabi Y. COVID-19-associated coagulopathy: role of vitamins D and K. Curr Pharm Biotechnol. 2022;24(3):401&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">35638271</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection.&#xa0;Front Immunol. 2022;13. 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Garg M, Jia T, Liao Q, Yuan L, Li M, et al. Single-cell analysis reveals the immune characteristics of myeloid cells and memory T cells in recovered COVID-19 patients with different severities. Front Immunol. 2022;12. 10.3389/fimmu.2021.781432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762286</ArticleId><ArticleId IdType="pubmed">35046942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy AE, Cook L, Breznik JA, Cowbrough B, Wallace JG, Huynh A, et al. Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections. Viruses. 2021;13(11). 10.3390/v13112239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8622816</ArticleId><ArticleId IdType="pubmed">34835045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawar AS, Dauod AS. Long COVID-19 prevalence among a sample of infected people in Erbil city. J Popul Ther Clin Pharmacol. 2022;29(3):e123&#x2013;e133.</Citation><ArticleIdList><ArticleId IdType="pubmed">36196947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, Garcia-Valtanen P, Al-Delfi Z, Gummow J, Ferguson C, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Roukens AHE, Pothast CR, K&#xf6;nig M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19. Nat Immunol. 2022;23(1):23&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">34937933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim SE, Kim T, Yun KW, Lee SH, Lee E, Seo JW, Jung YH, Chong YP. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect Chemother. 2022;54(3):566&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto MD, Chakraborty R, Lambert N. The elephant in the waiting room: an urgent call for papers to address the public health crisis of long COVID. Clin Nurs Res. 2022;31(8):1387&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9548489</ArticleId><ArticleId IdType="pubmed">36200625</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor RJ, Preston N, Parkin A, Makower S, Ross D, Gee J, Halpin SJ, Horton M, Sivan M. The COVID-19 Yorkshire rehabilitation scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort. J Med Virol. 2022;94(3):1027&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gees J, Makower S, Parkin A, Ross D, et al. The self-report version and digital format of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) for long Covid or post-COVID syndrome assessment and monitoring.&#xa0;J Clin Neurosci Rehabil. 2021;20(3). 10.47795/QROO4168.</Citation></Reference><Reference><Citation>Bonenfant J, Li J, Nasouf L, Miller J, Lowe T, Jaroszewski L, Qiu X, Thapamagar S, Mittal A, Godzik A, et al. Resistin concentration in early sepsis and all-cause mortality at a safety-net hospital in riverside county. J Inflamm Res. 2022;15:3925&#x2013;3940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9289958</ArticleId><ArticleId IdType="pubmed">35860230</ArticleId></ArticleIdList></Reference><Reference><Citation>Quick facts: Riverside County, CA. https://www.census.gov/quickfacts/riversidecountycalifornia. Accessed 14 Feb 2023.</Citation></Reference><Reference><Citation>Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney JAC, Bamford L, Wooten D, Karris MY, Mathews WC, Kim HN, et al. Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States. AIDS. 2022;36(8):1095&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273020</ArticleId><ArticleId IdType="pubmed">35796731</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6:94&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6616181</ArticleId><ArticleId IdType="pubmed">31363513</ArticleId></ArticleIdList></Reference><Reference><Citation>Riverside University Health System &#x2014; Public Health, Epidemiology &amp; Program Evaluation. https://www.ruhealth.org/public-health/epidemiology-program-evaluation. Accessed 15 June 2023.</Citation></Reference><Reference><Citation>Patel S. Health insurance and health service utilization among children. Riverside University Health System-Public Health. 2017;9(1).</Citation></Reference><Reference><Citation>Meconis, K. Health insurance coverage among adults. Riverside University Health System-Public Health. 2017;(9)2.</Citation></Reference><Reference><Citation>Occupational outlook handbook, labor force statistics from the current population survey. https://www.bls.gov/cps/cpsaat10.htm. Accessed 15 June 2023.</Citation></Reference><Reference><Citation>U.S. Census Bureau. https://data.census.gov/profile/Riverside_County,_C...?g=050XX00US06065. Accessed 15 June 2023.</Citation></Reference><Reference><Citation>Lopez L, III, Hart LH, III, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA. 2021;325(8):719&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">33480972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao X, Yip T, Fisher CB. Psychological well-being and substance use during the COVID-19 pandemic: ethnic/racial identity, discrimination, and vigilance. J Racial Ethn Health Disparities. 2022:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9795950</ArticleId><ArticleId IdType="pubmed">36576694</ArticleId></ArticleIdList></Reference><Reference><Citation>Shkurnikov MY, Averinskaya DA, Komarov AG, Karbyshev IA, Speshilov GI, Shtinova IA, Doroshenko DA, Vechorko VI, Drapkina OM. Association of HLA class i genotype with mortality in patients with diabetes mellitus and COVID-19. Dokl Biochem Biophys. 2022;507(1):289&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9926432</ArticleId><ArticleId IdType="pubmed">36786988</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, et al. Immune response in COVID-19: what is next? Cell Death Differ. 2022;29(6):1107&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110941</ArticleId><ArticleId IdType="pubmed">35581387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley GE, Edwards ESJ, Aui PM, Varese N, Stojanovic S, McMahon J, et al. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.&#xa0;Sci Immunol. 2020;5(54):eabf8891. 10.1126/sciimmunol.abf8891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877496</ArticleId><ArticleId IdType="pubmed">33443036</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29(7):1063&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233571</ArticleId><ArticleId IdType="pubmed">34174992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi K, Yukioka H, Hayashi M, Asada A. Elevated methemoglobin in patients with sepsis. Acta Anaesthesiol Scand. 1998;42(6):713&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">9689279</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoncini S, Rossi V, Signorini C, Tanganelli I, Comporti M, Ciccoli L. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients. Free Radic Res. 2008;42(8):716&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pubmed">18668391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bains SK, Foresti R, Howard J, Atwal S, Green CJ, Motterlini R. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity. Arterioscler Thromb Vasc Biol. 2010;30(2):305&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">19965783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaikijurajai T, Tang WHW. Myeloperoxidase: a potential therapeutic target for coronary artery disease. Expert Opin Ther Targets. 2020;24(7):695&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387188</ArticleId><ArticleId IdType="pubmed">32336171</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel V, Mariano D, Cant&#xe3;o LXS, Bastos LL, Fischer P, de Lima LHF, Fassio AV, de Melo-Minardi RC. VTR: a web tool for identifying analogous contacts on protein structures and their complexes. Front Bioinform. 2021;1:730350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9581016</ArticleId><ArticleId IdType="pubmed">36303745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950&#x2013;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, Charney AW, Narula J, Fayad ZA, Bagiella E, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(1):122&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202841</ArticleId><ArticleId IdType="pubmed">32387623</ArticleId></ArticleIdList></Reference><Reference><Citation>Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">15531878</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Li H, Liu S, Jia J, Zheng Y, Cao B. Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection. Front Microbiol. 2022;13:854172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9039618</ArticleId><ArticleId IdType="pubmed">35495713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Guo R, Lei L, Liu H, Wang Y, Qian H, Dai T, Zhang T, Lai Y, Wang J, et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2021;109(1):13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675546</ArticleId><ArticleId IdType="pubmed">33040384</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, Ba&#xdf;ler K, Schlickeiser S, Zhang B, Kr&#xe4;mer B, Krammer T, Brumhard S, Bonaguro L, et al. Severe COVID-19 Is marked by a dysregulated myeloid cell compartment. Cell. 2020;182(6):1419&#x2013;1440.e1423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, et al. Complex immune dysregulation in covid-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992&#x2013;1000.e1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020;92:2283&#x2013;2285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267383</ArticleId><ArticleId IdType="pubmed">32343429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan,&#xa0;China. Intensive Care Med. 2020;46:846&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pubmed">30943338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115(2):233&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Parkin A, Makower S, Greenwood DC. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service. J Med Virol. 2022;94(4):1419&#x2013;1427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Straudi S, Manfredini F, Baroni A, Milani G, Fregna G, Schincaglia N, et al. Construct validity and responsiveness of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in a cohort of Italian hospitalized COVID-19 patients. Int J Environ Res Public Health. 2022;19(11). 10.3390/ijerph19116696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9180312</ArticleId><ArticleId IdType="pubmed">35682280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garc&#xed;a B, Besteiro Balado Y, P&#xe9;rez L&#xf3;pez A, Romay Lema E, March&#xe1;n-L&#xf3;pez &#xc1;, Rodr&#xed;guez &#xc1;lvarez A, Garc&#xed;a Pa&#xed;s MJ, Corredoira S&#xe1;nchez J, Rabu&#xf1;al Rey R. Assessment of post-covid symptoms using the c19-yrs tool in a cohort of patients from the first pandemic wave in northwestern Spain. Telemedicine and e-Health. 2022;29(2):278&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">35727139</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>